AGT and dementia: As compared to patients who received angiotensin-II stimulating antihypertensive drugs, those who received angiotensin-II inhibiting drugs were significantly more likely to develop AD (adjusted hazard ratio: 1.15, 95% CI: 1.01–1.32), vascular dementia (1.27, 1.06–1.53), MCI (1.27, 1.02–1.59), other dementia (1.22, 1.15–1.30), and total ADRD (1.21, 1.14–1.28), but had no significantly different risk of DLB and FTD.